Risks of Endoscopic Retrograde Cholangiopancreatography and Sphincterotomy

Techniques in Gastrointestinal Endoscopy

Volumn 10, Issue 1, 2008, Pages 14-21

  Rochester, Jeremy ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

complications; ERCP; hemorrhage; pancreatitis; perforation; sphincterotomy

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; CONTRAST MEDIUM; GABEXATE MESILATE; GLUCOCORTICOID; GLYCERYL TRINITRATE; HEPARIN; INTERLEUKIN 10; IONIC CONTRAST MEDIUM; NIFEDIPINE; NONIONIC CONTRAST MEDIUM; OCTREOTIDE; PANCREAS ENZYME; SOMATOSTATIN; STEROID;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BALLOON DILATATION; BILE DUCT INJURY; BILIARY TRACT DISEASE; BILIARY TRACT DRAINAGE; BLEEDING; CHOLANGITIS; CHOLECYSTITIS; CLINICAL TRIAL; COMMON BILE DUCT STONE; DUODENUM PERFORATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ESOPHAGUS PERFORATION; HIGH RISK PATIENT; HUMAN; ODDI SPHINCTER; PANCREAS DISEASE; PANCREATITIS; RISK FACTOR; SEPSIS; SPHINCTEROTOMY; STENT; STOMACH PERFORATION;

EID: 37249035190     PISSN: 10962883     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tgie.2007.08.006     Document Type: Article

References (85)

1. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 335 (1996) 909-918
2. Elfant A.B., Bourke M.J., Alhalel R., et al. A prospective study of the safety of endoscopic therapy for choledocholithiasis in an outpatient population. Am J Gastroenterol 91 (1996) 1499-1502
3. Bergman J.J., van der Mey S., Rauws E.A., et al. Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc 44 (1996) 643-649
4. Loperfido S., Angelini G., Benedetti G., et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48 (1998) 1-10
5. Masci E., Toti G., Mariani A., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 96 (2001) 417-423
6. Freeman M.L., DiSario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
7. Vandervoort J., Soetikno R.M., Tham T.C., et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 56 (2002) 652-656
8. Christensen M., Matzen P., Schulze S., et al. Complications of ERCP: a prospective study. Gastrointest Endosc 60 (2004) 721-731
9. Suissa A., Yassin K., Lavy A., et al. Outcome and early complications of ERCP: a prospective single center study. Hepatogastroenterology 52 (2005) 352-355
10. Cheng C.L., Sherman S., Watkins J.L., et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101 (2006) 139-147
11. Froehlich F., Gonvers J.J., Vader J.P., et al. Appropriateness of gastrointestinal endoscopy: risk of complications. Endoscopy 31 (1999) 684-686
12. Pezzilli R., Billi P., Morselli-Labate A.M., et al. Anesthesiological risk and endoscopic sphincterotomy in acute biliary pancreatitis. Pancreas 26 (2003) 334-338
13. Deans G.T., Sedman P., Martin D.F., et al. Are complications of endoscopic sphincterotomy age related?. Gut 41 (1997) 545-548
14. Pezzilli R., Romboli E., Campana D., et al. Mechanisms involved in the onset of post-ERCP pancreatitis. JOP 3 (2002) 162-168
15. Hui C.K., Lai K.C., Wong W.M., et al. Outpatients undergoing therapeutic endoscopic retrograde cholangiopancreatography: six-hour versus overnight observation. J Gastroenterol Hepatol 19 (2004) 1163-1168
16. Sultan S., and Baillie J. What are the predictors of post-ERCP pancreatitis, and how useful are they?. JOP 3 (2002) 188-194
17. Thomas P.R., and Sengupta S. Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4-h post procedure amylase level. J Gastroenterol Hepatol 16 (2001) 923-926
18. Laugier R., Bernard J.P., Berthezene P., et al. Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly. Digestion 50 (1991) 202-211
19. Singh P., Gurudu S.R., Davidoff S., et al. Sphincter of oddi manometry does not predispose to post-ERCP acute pancreatitis. Gastrointest Endosc 59 (2004) 499-505
20. Sherman S., Hawes R.H., Troiano F.P., et al. Pancreatitis following bile duct sphincter of oddi manometry: utility of the aspirating catheter. Gastrointest Endosc 38 (1992) 347-350
21. Mehta S.N., Pavone E., Barkun J.S., et al. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 30 (1998) 457-463
22. Tanner A.R. ERCP: present practice in a single region. suggested standards for monitoring performance. Eur J Gastroenterol Hepatol 8 (1996) 145-148
23. Kaffes A.J., Sriram P.V., Rao G.V., et al. Early institution of pre-cutting for difficult biliary cannulation: a prospective study comparing conventional vs. a modified technique. Gastrointest Endosc 62 (2005) 669-674
24. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 39 (1993) 652-657
25. Tarnasky P.R., Palesch Y.Y., Cunningham J.T., et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of oddi dysfunction. Gastroenterology 115 (1998) 1518-1524
26. Aizawa T., and Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 54 (2001) 209-213
27. Fazel A., Quadri A., Catalano M.F., et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc 57 (2003) 291-294
28. Singh P., Das A., Isenberg G., et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis?. A meta-analysis of controlled trials. Gastrointest Endosc 60 (2004) 544-550
29. Rashdan A., Fogel E.L., McHenry Jr. L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329
30. Freeman M.L., Overby C., and Qi D. Pancreatic stent insertion: Consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 59 (2004) 8-14
31. Prat F., Amaris J., Ducot B., et al. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc 56 (2002) 202-208
32. Moreto M., Zaballa M., Casado I., et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57 (2003) 1-7
33. Dumot J.A., Conwell D.L., Zuccaro Jr. G., et al. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 96 (2001) 2098-2102
34. Dumot J.A., Conwell D.L., O'Connor J.B., et al. Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol 93 (1998) 61-65
35. Budzynska A., Marek T., Nowak A., et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 33 (2001) 766-772
36. Rabenstein T., Fischer B., Wiessner V., et al. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 59 (2004) 606-613
37. Cavallini G., Tittobello A., Frulloni L., et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography: gabexate in digestive endoscopy-italian group. N Engl J Med 335 (1996) 919-923
38. Masci E., Cavallini G., Mariani A., et al. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol 98 (2003) 2182-2186
39. Andriulli A., Solmi L., Loperfido S., et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2 (2004) 713-718
40. Andriulli A., Clemente R., Solmi L., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
41. Poon R.T., Yeung C., Lo C.M., et al. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 49 (1999) 593-598
42. Andriulli A., Leandro G., Niro G., et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51 (2000) 1-7
43. Binmoeller K.F., Harris A.G., Dumas R., et al. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?. Gut 33 (1992) 1129-1133
44. Binmoeller K.F., Dumas R., Harris A.G., et al. Effect of somatostatin analog octreotide on human sphincter of oddi. Dig Dis Sci 37 (1992) 773-777
45. Johnson G.K., Geenen J.E., Bedford R.A., et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. midwest pancreaticobiliary study group. Gastrointest Endosc 42 (1995) 312-316
46. Mishkin D., Carpenter S., Croffie J., et al. ASGE technology status evaluation report: radiographic contrast media used in ERCP. Gastrointest Endosc 62 (2005) 480-484
47. Lella F., Bagnolo F., Colombo E., et al. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc 59 (2004) 830-834
48. Stefanidis G., Karamanolis G., Viazis N., et al. A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis. Gastrointest Endosc 57 (2003) 192-197
49. Norton I.D., Petersen B.T., Bosco J., et al. A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveforms. Clin Gastroenterol Hepatol 3 (2005) 1029-1033
50. Wilcox C.M., Canakis J., Monkemuller K.E., et al. Patterns of bleeding after endoscopic sphincterotomy, the subsequent risk of bleeding, and the role of epinephrine injection. Am J Gastroenterol 99 (2004) 244-248
51. Oren A., Breumelhof R., Timmer R., et al. Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding?. Eur J Gastroenterol Hepatol 11 (1999) 1093-1097
52. Hui C.K., Lai K.C., Yuen M.F., et al. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding?. Aliment Pharmacol Ther 16 (2002) 929-936
53. Kuran S., Parlak E., Oguz D., et al. Endoscopic sphincterotomy-induced hemorrhage: treatment with heat probe. Gastrointest Endosc 63 (2006) 506-511
54. Oviedo J.A., Barrison A., and Lichtenstein D.R. Endoscopic argon plasma coagulation for refractory postsphincterotomy bleeding: report of two cases. Gastrointest Endosc 58 (2003) 148-151
55. Stapfer M., Selby R.R., Stain S.C., et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy. Ann Surg 232 (2000) 191-198
56. Howard T.J., Tan T., Lehman G.A., et al. Classification and management of perforations complicating endoscopic sphincterotomy. Surgery 126 (1999) 658-663 discussion 664-665
57. Enns R., Eloubeidi M.A., Mergener K., et al. ERCP-related perforations: risk factors and management. Endoscopy 34 (2002) 293-298
58. van den Hazel S.J., Speelman P., Dankert J., et al. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized, controlled trial. Ann Intern Med 125 (1996) 442-447
59. Sauter G., Grabein B., Huber G., et al. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. A randomized controlled study. Endoscopy 22 (1990) 164-167
60. Mehal W.Z., Culshaw K.D., Tillotson G.S., et al. Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. Eur J Gastroenterol Hepatol 7 (1995) 841-845
61. Niederau C., Pohlmann U., Lubke H., et al. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: results of a randomized controlled clinical study. Gastrointest Endosc 40 (1994) 533-537
62. Subhani J.M., Kibbler C., and Dooley J.S. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 13 (1999) 103-116
63. Davis A.J., Kolios G., Alveyn C.G., et al. Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 12 (1998) 207-211
64. Hirota W.K., Petersen K., Baron T.H., et al. Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 58 (2003) 475-482
65. Bergman J.J., van Berkel A.M., Groen A.K., et al. Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy. Gastrointest Endosc 45 (1997) 400-405
66. Costamagna G., Tringali A., Shah S.K., et al. Long-term follow-up of patients after endoscopic sphincterotomy for choledocholithiasis, and risk factors for recurrence. Endoscopy 34 (2002) 273-279
67. Tham T.C., Carr-Locke D.L., and Collins J.S. Endoscopic sphincterotomy in the young patient: is there cause for concern?. Gut 40 (1997) 697-700
68. Hawes R.H., Cotton P.B., and Vallon A.G. Follow-up 6 to 11 years after duodenoscopic sphincterotomy for stones in patients with prior cholecystectomy. Gastroenterology 98 (1990) 1008-1012
69. Lau J.Y., Leow C.K., Fung T.M., et al. Cholecystectomy or gallbladder in situ after endoscopic sphincterotomy and bile duct stone removal in chinese patients. Gastroenterology 130 (2006) 96-103
70. Isayama H., Komatsu Y., Inoue Y., et al. Preserved function of the oddi sphincter after endoscopic papillary balloon dilation. Hepatogastroenterology 50 (2003) 1787-1791
71. Minami A., Nakatsu T., Uchida N., et al. Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones. A randomized trial with manometric function. Dig Dis Sci 40 (1995) 2550-2554
72. Ochi Y., Mukawa K., Kiyosawa K., et al. Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol 14 (1999) 90-96
73. Yasuda I., Tomita E., Enya M., et al. Can endoscopic papillary balloon dilation really preserve sphincter of oddi function?. Gut 49 (2001) 686-691
74. Bergman J.J., Rauws E.A., Fockens P., et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet 349 (1997) 1124-1129
75. Vlavianos P., Chopra K., Mandalia S., et al. Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut 52 (2003) 1165-1169
76. Fujita N., Maguchi H., Komatsu Y., et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc 57 (2003) 151-155
77. Arnold J.C., Benz C., Martin W.R., et al. Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy 33 (2001) 563-567
78. Disario J.A., Freeman M.L., Bjorkman D.J., et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 127 (2004) 1291-1299
79. Baron T.H., and Harewood G.C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 99 (2004) 1455-1460
80. Natsui M., Narisawa R., Motoyama H., et al. What is an appropriate indication for endoscopic papillary balloon dilation?. Eur J Gastroenterol Hepatol 14 (2002) 635-640
81. Sato D., Shibahara T., Miyazaki K., et al. Efficacy of endoscopic nasobiliary drainage for the prevention of pancreatitis after papillary balloon dilatation: a pilot study. Pancreas 31 (2005) 93-97
82. Tanaka S., Sawayama T., and Yoshioka T. Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial. Gastrointest Endosc 59 (2004) 614-618
83. Bergman J.J., van Berkel A.M., Bruno M.J., et al. Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia?. Endoscopy 33 (2001) 416-420
84. Park do H., Kim M.H., Lee S.K., et al. Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc 60 (2004) 180-185
85. Bergman J.J., van Berkel A.M., Bruno M.J., et al. A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior billroth II gastrectomy. Gastrointest Endosc 53 (2001) 19-26